Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11042573rdf:typepubmed:Citationlld:pubmed
pubmed-article:11042573lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:11042573lifeskim:mentionsumls-concept:C0020792lld:lifeskim
pubmed-article:11042573lifeskim:mentionsumls-concept:C0476089lld:lifeskim
pubmed-article:11042573lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:11042573lifeskim:mentionsumls-concept:C0205422lld:lifeskim
pubmed-article:11042573lifeskim:mentionsumls-concept:C1519302lld:lifeskim
pubmed-article:11042573lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:11042573lifeskim:mentionsumls-concept:C0449774lld:lifeskim
pubmed-article:11042573lifeskim:mentionsumls-concept:C2348235lld:lifeskim
pubmed-article:11042573pubmed:issue8lld:pubmed
pubmed-article:11042573pubmed:dateCreated2000-11-20lld:pubmed
pubmed-article:11042573pubmed:abstractTextLoss of heterozygosity (LOH) at chromosome 10q25-q26 has been reported previously in endometrial carcinoma (EC), suggesting the presence of tumor suppressor gene(s). Nevertheless, frequency of genome-wide microsatellite instability (MSI) has been demonstrated higher in EC than in other common malignancy, mostly due to defective DNA mismatch repair. The authors further evaluated the role of the chromosome 10q25-q26 in endometrial tumorigenesis as well as the clinical significance of any observed genetic alteration in sporadic EC.lld:pubmed
pubmed-article:11042573pubmed:languageenglld:pubmed
pubmed-article:11042573pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11042573pubmed:citationSubsetAIMlld:pubmed
pubmed-article:11042573pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11042573pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11042573pubmed:statusMEDLINElld:pubmed
pubmed-article:11042573pubmed:monthOctlld:pubmed
pubmed-article:11042573pubmed:issn0008-543Xlld:pubmed
pubmed-article:11042573pubmed:authorpubmed-author:MassarelliGGlld:pubmed
pubmed-article:11042573pubmed:authorpubmed-author:TandaFFlld:pubmed
pubmed-article:11042573pubmed:authorpubmed-author:PalmieriGGlld:pubmed
pubmed-article:11042573pubmed:authorpubmed-author:PintusAAlld:pubmed
pubmed-article:11042573pubmed:authorpubmed-author:CostePPlld:pubmed
pubmed-article:11042573pubmed:authorpubmed-author:PisanoMMlld:pubmed
pubmed-article:11042573pubmed:authorpubmed-author:CherchiPPlld:pubmed
pubmed-article:11042573pubmed:authorpubmed-author:PirastuMMlld:pubmed
pubmed-article:11042573pubmed:authorpubmed-author:MancaAAlld:pubmed
pubmed-article:11042573pubmed:authorpubmed-author:DessoleSSlld:pubmed
pubmed-article:11042573pubmed:authorpubmed-author:RuiuGGlld:pubmed
pubmed-article:11042573pubmed:copyrightInfoCopyright 2000 American Cancer Society.lld:pubmed
pubmed-article:11042573pubmed:issnTypePrintlld:pubmed
pubmed-article:11042573pubmed:day15lld:pubmed
pubmed-article:11042573pubmed:volume89lld:pubmed
pubmed-article:11042573pubmed:ownerNLMlld:pubmed
pubmed-article:11042573pubmed:authorsCompleteYlld:pubmed
pubmed-article:11042573pubmed:pagination1773-82lld:pubmed
pubmed-article:11042573pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11042573pubmed:meshHeadingpubmed-meshheading:11042573...lld:pubmed
pubmed-article:11042573pubmed:meshHeadingpubmed-meshheading:11042573...lld:pubmed
pubmed-article:11042573pubmed:meshHeadingpubmed-meshheading:11042573...lld:pubmed
pubmed-article:11042573pubmed:meshHeadingpubmed-meshheading:11042573...lld:pubmed
pubmed-article:11042573pubmed:meshHeadingpubmed-meshheading:11042573...lld:pubmed
pubmed-article:11042573pubmed:meshHeadingpubmed-meshheading:11042573...lld:pubmed
pubmed-article:11042573pubmed:meshHeadingpubmed-meshheading:11042573...lld:pubmed
pubmed-article:11042573pubmed:meshHeadingpubmed-meshheading:11042573...lld:pubmed
pubmed-article:11042573pubmed:meshHeadingpubmed-meshheading:11042573...lld:pubmed
pubmed-article:11042573pubmed:meshHeadingpubmed-meshheading:11042573...lld:pubmed
pubmed-article:11042573pubmed:meshHeadingpubmed-meshheading:11042573...lld:pubmed
pubmed-article:11042573pubmed:meshHeadingpubmed-meshheading:11042573...lld:pubmed
pubmed-article:11042573pubmed:meshHeadingpubmed-meshheading:11042573...lld:pubmed
pubmed-article:11042573pubmed:meshHeadingpubmed-meshheading:11042573...lld:pubmed
pubmed-article:11042573pubmed:meshHeadingpubmed-meshheading:11042573...lld:pubmed
pubmed-article:11042573pubmed:meshHeadingpubmed-meshheading:11042573...lld:pubmed
pubmed-article:11042573pubmed:year2000lld:pubmed
pubmed-article:11042573pubmed:articleTitleMicrosatellite analysis at 10q25-q26 in Sardinian patients with sporadic endometrial carcinoma: identification of specification patterns of genetic alteration.lld:pubmed
pubmed-article:11042573pubmed:affiliationInstitute of Molecular Genetics, C.N.R., Alghero, Italy. gpalmieri@yahoo.comlld:pubmed
pubmed-article:11042573pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11042573pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed